Kaposiform lymphangiomatosis: Diagnosis, pathogenesis, and treatment

Pediatr Blood Cancer. 2023 Apr;70(4):e30219. doi: 10.1002/pbc.30219. Epub 2023 Jan 22.


Kaposiform lymphangiomatosis (KLA) is a life-threatening rare disease that can cause substantial morbidity, mortality, and social burdens for patients and their families. Diagnosis often occurs long after initial symptoms, and there are few centers in the world with the expertise to diagnose and care for patients with the disease. KLA is a lymphatic anomaly and significant advancements have been made in understanding its pathogenesis and etiology since its first description in 2014. This review provides multidisciplinary, comprehensive, and state-of-the-art information on KLA patient presentation, diagnostic imaging, pathology, organ involvement, genetics, and pathogenesis. Finally, we describe current therapeutic approaches, important areas for research, and challenges faced by patients and their families. Further insights into the pathogenesis of KLA may advance our understanding of other vascular anomalies given that similar signaling pathways may be involved.

Keywords: kaposiform lymphangiomatosis; lymphatic anomalies; rare diseases.

Publication types

  • Review

MeSH terms

  • Humans
  • Lymphatic Abnormalities*
  • Signal Transduction